01 6MSD SUB MERCK
01 69308204
01 6Blank
01 6Y
01 62030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209805
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209806
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209806
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209806
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209806
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
Patent Expiration Date : 2030-10-21
ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
US Patent Number : 9308204
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209805
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-21
